Sanz Ana Belen, Santamaría Beatriz, Ruiz-Ortega Marta, Egido Jesus, Ortiz Alberto
Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Fundación Renal Iñigo Alvarez de Toledo and ISCIII-RETIC REDinREN 6/16, Madrid, Spain.
J Am Soc Nephrol. 2008 Sep;19(9):1634-42. doi: 10.1681/ASN.2007121336. Epub 2008 Jul 16.
Apoptotic cell death is usually a response to the cell microenvironment. Apoptosis requires the activation of lethal molecules and the inactivation of prosurvival ones. Both are potential therapeutic targets. Apoptosis contributes to parenchymal cell loss in the course of acute and chronic renal injury. Apoptotic pathways that are active in glomerular and tubular epithelium include death induced by survival factor deprivation, death receptor activation, mitochondrial injury, endoplasmic reticulum stress, lysosomal destabilization, and caspase cascade activation. These pathways are not mutually exclusive, and stimulus-specific differences in the recruitment of apoptotic pathways have been observed. In some cases, the activation of a certain death pathway is redundant, and its inhibition does not prevent eventual cell death. This review summarizes recent advances in the field and discusses the rational basis to choose from the available tools to target apoptosis therapeutically.
凋亡性细胞死亡通常是对细胞微环境的一种反应。凋亡需要致死分子的激活和促生存分子的失活。两者都是潜在的治疗靶点。凋亡在急性和慢性肾损伤过程中导致实质细胞丢失。在肾小球和肾小管上皮细胞中活跃的凋亡途径包括生存因子剥夺诱导的死亡、死亡受体激活、线粒体损伤、内质网应激、溶酶体不稳定和半胱天冬酶级联激活。这些途径并非相互排斥,并且已经观察到凋亡途径募集过程中刺激特异性的差异。在某些情况下,特定死亡途径的激活是多余的,其抑制并不能阻止最终的细胞死亡。本综述总结了该领域的最新进展,并讨论了从可用工具中选择针对凋亡进行治疗的合理依据。